Quanterix Co. (NASDAQ:QTRX) Shares Purchased by Easterly Investment Partners LLC

Easterly Investment Partners LLC increased its position in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) by 9.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 954,995 shares of the company's stock after purchasing an additional 78,862 shares during the quarter. Easterly Investment Partners LLC owned 2.48% of Quanterix worth $10,152,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of QTRX. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Quanterix during the third quarter worth about $500,000. Intech Investment Management LLC acquired a new position in shares of Quanterix during the 3rd quarter worth approximately $170,000. Algert Global LLC lifted its stake in Quanterix by 75.9% in the 3rd quarter. Algert Global LLC now owns 137,833 shares of the company's stock valued at $1,786,000 after buying an additional 59,496 shares in the last quarter. FMR LLC grew its holdings in Quanterix by 112.6% during the 3rd quarter. FMR LLC now owns 30,242 shares of the company's stock valued at $392,000 after buying an additional 16,020 shares during the last quarter. Finally, Portolan Capital Management LLC grew its holdings in Quanterix by 31.4% during the 3rd quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company's stock valued at $32,668,000 after buying an additional 602,656 shares during the last quarter. 86.48% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on QTRX. Canaccord Genuity Group cut their price target on Quanterix from $20.00 to $15.00 and set a "buy" rating for the company in a report on Tuesday, March 18th. Scotiabank restated an "outperform" rating on shares of Quanterix in a research report on Tuesday, March 25th.

Quanterix Stock Down 1.1 %

Shares of QTRX traded down $0.08 during mid-day trading on Monday, hitting $6.49. The company had a trading volume of 240,682 shares, compared to its average volume of 513,741. The stock has a market cap of $251.46 million, a PE ratio of -6.10 and a beta of 1.33. Quanterix Co. has a 1-year low of $6.14 and a 1-year high of $23.86. The business's 50-day simple moving average is $7.99 and its 200-day simple moving average is $10.63.

Quanterix (NASDAQ:QTRX - Get Free Report) last released its quarterly earnings data on Monday, March 17th. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). The firm had revenue of $35.16 million for the quarter, compared to analyst estimates of $34.93 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. On average, sell-side analysts expect that Quanterix Co. will post -0.98 earnings per share for the current year.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.